192 related articles for article (PubMed ID: 2542839)
1. Control of opiate receptor number in vivo: simultaneous kappa-receptor down-regulation and mu-receptor up-regulation following chronic agonist/antagonist treatment.
Morris BJ; Herz A
Neuroscience; 1989; 29(2):433-42. PubMed ID: 2542839
[TBL] [Abstract][Full Text] [Related]
2. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
Richards ML; Sadée W
J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
Tiberi M; Magnan J
Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
[TBL] [Abstract][Full Text] [Related]
4. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
Devlin T; Shoemaker WJ
J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
[TBL] [Abstract][Full Text] [Related]
5. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
Morris BJ; Millan MJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine.
Morris BJ; Herz A
Neuroscience; 1986 Nov; 19(3):839-46. PubMed ID: 3025770
[TBL] [Abstract][Full Text] [Related]
7. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
Richards ML; Sadée W
Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
[TBL] [Abstract][Full Text] [Related]
8. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
9. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment.
Attali B; Vogel Z
Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
11. Novel opiate binding sites selective for benzomorphan drugs.
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
[TBL] [Abstract][Full Text] [Related]
12. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats.
Sumner BE; Coombes JE; Pumford KM; Russell JA
Neuroscience; 1990; 37(3):635-45. PubMed ID: 2174133
[TBL] [Abstract][Full Text] [Related]
14. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
15. Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus.
Corbett AD; Kosterlitz HW
Br J Pharmacol; 1986 Sep; 89(1):245-9. PubMed ID: 3026544
[TBL] [Abstract][Full Text] [Related]
16. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
17. Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine.
Quirion R; Pilapil C; Magnan J
Cell Mol Neurobiol; 1987 Sep; 7(3):303-7. PubMed ID: 2830975
[TBL] [Abstract][Full Text] [Related]
18. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
19. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
Dunwiddie TV; Johnson KJ; Proctor WR
Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of the mu-, delta-, and kappa-opiate receptor subtypes by guanyl nucleotides and metal ions.
Pfeiffer A; Sadée W; Herz A
J Neurosci; 1982 Jul; 2(7):912-7. PubMed ID: 6284888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
